JNJ vs META
AI-powered side-by-side analysis. Updated every 2 hours.
Divergence: JNJ is bullish while META is bearish. Diverging directions between related stocks can signal sector rotation or company-specific catalysts.
Johnson & Johnson Eyes Double-Digit Revenue Growth
- • JNJ stock up 18.74% in Q1 2026
- • FDA approved ICOTYDE, potentially $5B-$10B sales
- • Insiders sold $127M shares recently
Meta to surpass Google in digital ads revenue
- • Meta's 2026 digital ad revenue projected at $243.5 billion, up 24% YoY
- • Meta's Muse Spark AI model scored 52 on Intelligence Index
- • $21 billion AI cloud capacity deal with CoreWeave through 2032
How This Works
The Read analyzes 50+ financial sources every 2 hours and maintains AI-scored positions on 40+ stocks. Each entity is independently evaluated based on insider activity, analyst ratings, earnings data, SEC filings, and news signals. See our track record.
This comparison updates automatically whenever either stock's analysis changes. Every prediction is timestamped and scored against real prices.
More Comparisons
Explore more